Clinical Trial Update: IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating IB-T101 injection for advanced clear cell renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• IB-T101

Snippet

Sponsor: Grit Biotechnology | Conditions: Advanced Clear Renal Cell Carcinoma, Adult | Phase 1 | Status: RECRUITING